Patent · US Active

Anti-human folate receptor beta antibodies and methods of use

US9963505B2 · kind B2 · utility

0Cited by
3References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 8, 2016
Grant dateMay 8, 2018
Priority date
Expiry dateApr 8, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Human anti-human folate receptor beta antibodies and antigen-binding fragments thereof are described, as well as methods of using such antibodies and fragments to treat inflammatory disorders or cancers expressing cell surface FRβ.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.